The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

  • Novita Healthcare has signed a supply agreement with U.K. company Edtech Impact, for its Tali Train technology
  • More than 90 per cent of U.K. schools receive the Edtech Impact Guides
  • Technologies on Edtech’s platform are seen by over 180,000 teachers a month

Novita Healthcare has signed a supply agreement with U.K. company Edtech Impact, for its Tali Train technology.

Tali Train is a scientifically proven game-based training program for three to eight year-olds that helps treat attention issues in children. It is accessed through a tablet at home or in a classroom.

Technologies on Edtech’s platform are seen by over 180,000 teachers a month. Edtech undertakes targeted campaigns to teachers who have already opted-in to obtain first access and use of new technologies such as Tali Train.

More than 90 per cent of U.K. schools receive the Edtech Impact Guides that showcase a specific Edtech product with real life impact stories.

Tali Train will benefit from the U.K. schoolteacher communities as its the first line for complimentary early childhood intervention in the treatment of inattention.

Novita is a leading early childhood technology business that targets attention, or lack of, in children.

Chairman Sue MacLeman says this is a significant step forward for Novita as Edtech specifically targets schools that have already identified the need for tools such as Tali Train.

“In effect, this is a pool of prequalified high value sales targets that will assist to compress the sales cycle and potentially drive timely revenue generation for Tali in the U.K.,” she said.

Edtech and Novita will also partner on specific school leader only events and on the collection of data related to the use of social, economic and education impacts of Tali Train in the U.K. school system.

This will provide a base for potential expansion of the Tali technology into the National Health Scheme in the U.K. and provide a base for expansion into Europe.

Novita Healthcare is up 22.7 per cent on the ASX this morning and are selling shares for 1.4 cents apiece at 12:26 pm AEST.

NHL by the numbers
More From The Market Online

Orcoda heading into Q2 with new clients under belt via government-led pilot

Orcoda has announced it's heading into Q2 with 4 new clients in its healthcare logistics arm,…

Iress (ASX: IRE) strikes deal with Bain Capital for UK Mortgage Business Sale

Iress (ASX:IRE) has entered into a binding agreement to sell its UK Mortgage business to Bain…

Dotz Nano advances climate solutions with ‘Dotz Earth’

Dotz Nano is a leading developer of innovative climate and industrial technologies – and it's got…